BY NICK ZAGORSKI 

Although a majority of the ASBMB community hails from the world of academia, the society also has a rich and diverse set of members in the industry sector. In this article, we profile just a few of these “industrious” individuals to showcase the scope of research being carried out in this arena, from the traditional to the slightly more exotic.

BY NANCY VAN PROOYEN 

Nancy Van Prooyen looks at some of the new technology that is being used to clean up the BP oil spill.   

BY NICK ZAGORSKI 

A new agreement between the University of California, San Francisco and Genentech Inc. may be a turning point in how industry and academia conduct their business.

BY LESLIE W. CHINN 

Leslie W. Chinn talks with Stephen Cary of Omniox about starting up a biotech company and some of the resources available to fledgling start ups. 

BY GREGORY A. PETSKO

ASBMB Past-president Gregory A. Petsko explains why Phase II drug failures from pharmaceutical companies are the perfect subjects for academic research.